Home Increased CA 19-9 level in patients without malignant disease
Article
Licensed
Unlicensed Requires Authentication

Increased CA 19-9 level in patients without malignant disease

  • Hye-Ryoun Kim , Chang-Hyun Lee , Young Whan Kim , Sung Koo Han , Young-Soo Shim and Jae-Joon Yim
Published/Copyright: April 30, 2009

Abstract

Background: The measurement of carbohydrate antigen 19-9 (CA 19-9) is recommended for the diagnosis and follow-up of pancreatic cancer. However, increased CA 19-9 has also been reported in patients with various benign diseases of the lung. We aimed to elucidate the pulmonary radiographic abnormalities and laboratory results associated with increased concentrations of CA 19-9.

Methods: This study was performed using a case-controlled design. Cases included all participants in a cancer screening program who had an increased CA 19-9 concentration (>37 U/mL), but without a diagnosis of malignancy. Age- and sex-matched participants with normal CA 19-9 levels were enrolled as controls. Laboratory results and radiographic features were compared.

Results: In total, 119 participants with increased CA 19-9 concentrations and 476 controls were included. A higher erythrocyte sedimentation rate (ESR) [adjusted odd ratio (aOR), 1.03; 95% confidence interval (CI), 1.01–1.05], higher hemoglobin A1c (HbA1c) (aOR, 1.28; 95% CI, 1.05–1.56), bronchiectasis (aOR, 2.48; 95% CI, 1.22–5.02), bronchiolitis (aOR, 3.93; 95% CI, 1.88–8.22), emphysema (aOR, 2.67; 95% CI, 1.32–5.40), and interstitial fibrosis (aOR, 10.62; 95% CI, 2.03–55.44) were independent factors for increased CA 19-9.

Conclusions: CA 19-9 concentrations, as well as increased ESR and HbA1c, can be increased in patients with various lung abnormalities.

Clin Chem Lab Med 2009;47:750–4.


Corresponding author: Jae-Joon Yim, MD, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, 101 Daehangno, Jongno-gu, Seoul, 110-744, Republic of Korea Fax: +82-2-762-9662,

Received: 2008-12-17
Accepted: 2009-3-17
Published Online: 2009-04-30
Published in Print: 2009-06-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. A focus on recent advances in proteomics – one step closer to entrance into the clinical arena
  3. Reviews
  4. Proteomics in protein misfolding diseases
  5. Multidimensional protein identification technology for clinical proteomic analysis
  6. Technical advances in proteomics mass spectrometry: identification of post-translational modifications
  7. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
  8. Research Papers
  9. Thrombin induces broad spectrum proteolysis in human serum samples
  10. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)
  11. Proteomics of exhaled breath: methodological nuances and pitfalls
  12. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry
  13. Approaching clinical proteomics: current state and future fields of application in fluid proteomics
  14. Genetics and Molecular Diagnostics
  15. Detection of Hpdel in healthy individuals and cancer patients in Taiwan
  16. Increased CA 19-9 level in patients without malignant disease
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases
  19. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study
  20. Reference Values and Biological Variations
  21. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythrocyte mechanical properties
  22. Systemic cytokine response following exercise-induced muscle damage in humans
  23. Letters to the Editor
  24. CACNA1A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology
  25. Proficiency test of plasma free and total metanephrines: report from a study group
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.152/pdf
Scroll to top button